$4.240
-1.124 (-26.52%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
YDES Prediction & Forecast by Similar Chart Analysis
Alphio's YDES stock price prediction model matches the current YD Bio Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.00 (+1.00%). The 1-week path is $5.05 (+1.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy YD Bio Ltd Stock?
Yd Bio Ltd (YDES) is currently priced at $4.95, which is significantly down 58.75% year-to-date. The RSI is at 37.93, indicating it is nearing oversold territory, which could suggest a potential buying opportunity. However, the company has reported a negative EPS of -0.12 for Q4 2025 and a staggering net margin of -1392.61% for the same period, raising concerns about profitability. The main risk is the high volatility, as the stock has seen a 71.07% decline over the past year, indicating instability. Therefore, while there are signs of potential recovery, caution is advised before making a purchase.
YDES stock price ended at $4.24 on Thursday, after losing -26.52%
YD Bio Ltd (YDES) last closed at $4.95, gaining +16.75%. These facts feed the 1-day and 1-week YDES price prediction above.
Forecast Drivers
YD Bio Ltd (YDES) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches YDES, ranked by similarity.
Seasonality analysis for YDES
Historically the probability of a positive October return for YDES is 52.50%. October offers the highest probability of a positive month at 52.50%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.